Lombard Odier Asset Management (Switzerland)’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $6.17M | Buy |
219,693
+34,500
| +19% | +$919K | 0.23% | 95 |
|
|
2025
Q4 | $4.61M | Buy |
185,193
+171,477
| +1,250% | +$4.32M | 0.2% | 112 |
|
|
2025
Q3 | $10.9M | Sell |
13,716
-146,573
| -91% | -$3.62M | 0.49% | 36 |
|
|
2025
Q2 | $3.89M | Sell |
160,289
-41,359
| -21% | -$965K | 0.2% | 117 |
|
|
2025
Q1 | $5.11M | Buy |
201,648
+32,937
| +20% | +$862K | 0.29% | 83 |
|
|
2024
Q4 | $4.48M | Buy |
168,711
+31,286
| +23% | +$849K | 0.33% | 77 |
|
|
2024
Q3 | $3.98M | Sell |
137,425
-4,904
| -3% | -$143K | 0.33% | 81 |
|
|
2024
Q2 | $3.98M | Buy |
142,329
+3,865
| +3% | +$106K | 0.41% | 63 |
|
|
2024
Q1 | $3.84M | Buy |
138,464
+75,018
| +118% | +$2.08M | 0.27% | 101 |
|
|
2023
Q4 | $1.83M | Buy |
63,446
+21,136
| +50% | +$639K | 0.24% | 94 |
|
|
2023
Q3 | $1.4M | Sell |
42,310
-1,184
| -3% | -$41.9K | 0.23% | 86 |
|
|
2023
Q2 | $1.6M | Buy |
43,494
+2,804
| +7% | +$109K | 0.23% | 84 |
|
|
2023
Q1 | $1.66M | Sell |
40,690
-345,173
| -89% | -$14.9M | 0.14% | 136 |
|
|
2022
Q4 | $19.8M | Sell |
385,863
-45,035
| -10% | -$2.16M | 1.58% | 13 |
|
|
2022
Q3 | $18.9M | Buy |
430,898
+396,891
| +1,167% | +$19.3M | 1.6% | 17 |
|
|
2022
Q2 | $1.78M | Sell |
34,007
-3,783
| -10% | -$193K | 0.15% | 120 |
|
|
2022
Q1 | $1.96M | Buy |
37,790
+1,955
| +5% | +$101K | 0.15% | 93 |
|
|
2021
Q4 | $2.12M | Sell |
35,835
-8,265
| -19% | -$409K | 0.14% | 95 |
|
|
2021
Q3 | $1.78M | Buy |
44,100
+1,171
| +3% | +$51.9K | 0.11% | 113 |
|
|
2021
Q2 | $1.68M | Buy |
42,929
+9,963
| +30% | +$387K | 0.09% | 149 |
|
|
2021
Q1 | $1.19M | Buy |
32,966
+2,392
| +8% | +$84.9K | 0.08% | 141 |
|
|
2020
Q4 | $1.13M | Buy |
30,574
+3,424
| +13% | +$126K | 0.13% | 79 |
|
|
2020
Q3 | $945K | Buy |
27,150
+4,007
| +17% | +$140K | 0.1% | 152 |
|
|
2020
Q2 | $718K | Hold |
23,143
| – | – | 0.11% | 102 |
|
|
2020
Q1 | $717K | Sell |
23,143
-532,217
| -96% | -$18.1M | 0.1% | 152 |
|
|
2019
Q4 | $20.6M | Buy |
555,360
+521,380
| +1,534% | +$18.6M | 1.94% | 9 |
|
|
2019
Q3 | $1.16M | Buy |
33,980
+15,299
| +82% | +$556K | 0.13% | 143 |
|
|
2019
Q2 | $768K | Sell |
18,681
-551,599
| -97% | -$21.9M | 0.08% | 188 |
|
|
2019
Q1 | $23M | Sell |
570,280
-40,168
| -7% | -$1.61M | 2.33% | 5 |
|
|
2018
Q4 | $25.3M | Sell |
610,448
-1,329
| -0.2% | -$55.2K | 2.87% | 3 |
|
|
2018
Q3 | $25.6M | Buy |
611,777
+231,880
| +61% | +$8.93M | 2.54% | 5 |
|
|
2018
Q2 | $13.1M | Buy |
379,897
+42,618
| +13% | +$1.46M | 1.38% | 19 |
|
|
2018
Q1 | $11.4M | Sell |
337,279
-56,660
| -14% | -$1.95M | 1.18% | 25 |
|
|
2017
Q4 | $13.5M | Sell |
393,939
-36,890
| -9% | -$1.26M | 1.31% | 20 |
|
|
2017
Q3 | $14.6M | Buy |
430,829
+405,790
| +1,621% | +$13M | 1.42% | 21 |
|
|
2017
Q2 | $798K | Hold |
25,039
| – | – | 0.09% | 199 |
|
|
2017
Q1 | $813K | Sell |
25,039
-48,741
| -66% | -$1.54M | 0.09% | 205 |
|
|
2016
Q4 | $2.27M | Buy |
73,780
+21,080
| +40% | +$644K | 0.57% | 45 |
|
|
2016
Q3 | $1.69M | Sell |
52,700
-436,099
| -89% | -$14.6M | 0.4% | 44 |
|
|
2016
Q2 | $16.3M | Sell |
488,799
-63,240
| -11% | -$2.02M | 2.22% | 15 |
|
|
2016
Q1 | $15.5M | Buy |
552,039
+223,448
| +68% | +$6.38M | 1.84% | 16 |
|
|
2015
Q4 | $10.1M | Buy |
328,591
+293,804
| +845% | +$9.24M | 1.22% | 25 |
|
|
2015
Q3 | $1.04M | Sell |
34,787
-17,763
| -34% | -$570K | 0.1% | 89 |
|
|
2015
Q2 | $1.67M | Sell |
52,550
-9,697
| -16% | -$316K | 0.13% | 77 |
|
|
2015
Q1 | $2.07M | Sell |
62,247
-62,336
| -50% | -$1.98M | 0.23% | 75 |
|
|
2014
Q4 | $3.68M | Sell |
124,583
-699,522
| -85% | -$20.1M | 0.4% | 49 |
|
|
2014
Q3 | $23.2M | Buy |
824,105
+764,109
| +1,274% | +$21.4M | 0.6% | 36 |
|
|
2014
Q2 | $1.68M | Buy |
+59,996
| New | +$1.71M | 0.19% | 76 |
|
Other funds holding PFE
VCM
VPM
Lombard Odier Asset Management (Switzerland)'s PFE Position: Q1 2026 in Review
Lombard Odier Asset Management (Switzerland) increased its Pfizer (PFE) stake by 19% in Q1 2026, buying an estimated $919K and bringing the position to 219,693 shares worth $6.17M. The position accounts for 0.23% of the portfolio, ranked #95.
Lombard Odier Asset Management (Switzerland) first reported a position in PFE in Q2 2014 and has held it in 48 quarters since. The position peaked at $25.6M in Q3 2018. 2,939 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Lombard Odier Asset Management (Switzerland) held 219,693 shares of Pfizer worth $6.17M as of Q1 2026.
- Lombard Odier Asset Management (Switzerland) bought 34,500 Pfizer shares in Q1 2026, an estimated $919K.
- Pfizer made up 0.23% of Lombard Odier Asset Management (Switzerland)'s portfolio in Q1 2026, its #95 holding.
- Lombard Odier Asset Management (Switzerland) first reported a position in Pfizer in Q2 2014 and has held it in 48 quarters since.
- Lombard Odier Asset Management (Switzerland)'s Pfizer position peaked at $25.6M in Q3 2018.
- 2,939 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Lombard Odier Asset Management (Switzerland)'s 13F filing for Q1 2026, filed 15 May 2026.